Avelogreta2022-09-20T14:04:48+01:00 COMPANY INFO MEDTECH – Switzerland Current stage: Seed COMPANY PROFILE Avelo is a Swiss breath diagnostics company with a mission to save lives by bringing fast and actionable infectious disease diagnoses to primary care. NEWS Avelo receives CHF 1.5M Innosuisse Grant to Deliver an Innovative Breath Sampling Tool for LRTIsgreta2023-12-14T15:52:41+01:00December 14th, 2023|Read More Avelo closes CHF 2.2 million oversubscribed seed roundgreta2022-09-20T14:21:19+01:00September 20th, 2022|Read More
Avelo receives CHF 1.5M Innosuisse Grant to Deliver an Innovative Breath Sampling Tool for LRTIsgreta2023-12-14T15:52:41+01:00December 14th, 2023|Read More
Avelo closes CHF 2.2 million oversubscribed seed roundgreta2022-09-20T14:21:19+01:00September 20th, 2022|Read More